newsmetry
rusign inget started
macro

UBS keeps Biogen at Buy and raises price target to $300 from $270

According to TradingView, UBS maintained its Buy rating on Biogen and lifted its price target by 11.1%, from $270 to $300, versus the Oct 28 close of $244.05.

published on Newsmetry
original source published

the same feed is available to bots and dashboards through the api. connect the api →

Newsmetry newsroom

what happened

UBS analysts kept their Buy rating on Biogen shares and raised the price target from $270 to $300, an increase of 11.1%. TradingView, citing data from Benzinga, reports that the new target implies 22.9% upside from the Oct 28 closing price of $244.05.

The same source lists five recent analyst notes published over the past 30 days. TD Cowen and Truist Securities reiterated Buy with a $260 target, Baird kept an Outperform rating with a $290 target, Needham maintained Buy at $290, and Wedbush held Neutral at $225. In this sample, price targets range from $225 to $290.

why it matters

Analyst price targets do not directly reflect changes in a company's financial results, so market reactions to such revisions are usually moderate. The spread from $225 to $290 shows that opinions on the stock differ, and investors typically weigh company filings and news alongside analyst views.

tags

Analyst RatingStockUnited StatesBrazil

instruments

Biogen (BIIB)

sources

  1. UBS maintains Chemed at Buy, raises price target to $675 from $650 — TradingView, 29 October 2026 at 16:21 UTC
  2. UBS maintains Biogen at Buy, raises price target to $300 from $270 — TradingView, 29 October 2026 at 16:18 UTC
  3. UBS maintains Carvana at Buy, raises price target to $84 from $83 — TradingView, 29 October 2026 at 16:24 UTC
  4. UBS maintains The Chefs' Warehouse at Buy, raises price target to $135 from $125 — TradingView, 29 October 2026 at 16:22 UTC
  5. UBS maintains Gerdau at Buy, raises price target to $6.40 from $6.10 — TradingView, 29 October 2026 at 16:38 UTC
  6. UBS maintains Ensign Group at Buy, raises price target to $240 from $230 — TradingView, 29 October 2026 at 16:34 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

alerts on your topics, the morning digest and the api — in your account.

get stories in real time ↗

related stories